Aethlon Medical

Balance sheet: Cash and equivalents were about 5.0 million dollars at March 31, 2026; operating expenses were about 7.29 million dollars and net cash used in operations about 7.0 million dollars, leading the auditor to flag substantial doubt about going concern.

Post‑year‑end, the company raised approximately 1.85 million dollars via its ATM and about 3.34 million dollars net in a registered offering on July 6, 2026, modestly extending runway but increasing dilution. There is minimal financial debt, but continued equity funding appears necessary within the next 12 to 18 months absent non‑dilutive capital.